Literature DB >> 4849380

[Pharmacokinetic characteristics and biodegradation of aprindin in man].

L Dodion, J M de Suray, M Deblecker, A Georges.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4849380

Source DB:  PubMed          Journal:  Therapie        ISSN： 0040-5957            Impact factor:   2.070


× No keyword cloud information.
  4 in total

1.  Absorption, half-life, and toxicity of oral aprindine in patients with acute myocardial infarction.

Authors:  F Hagemeijer
Journal:  Eur J Clin Pharmacol       Date:  1975-10-10       Impact factor: 2.953

2.  Dose-dependent pharmacokinetics of aprindine in healthy volunteers.

Authors:  T Kobari; T Itoh; T Hirakawa; H Namekawa; T Suzuki; T Satoh; N Iida; F Ohtsu; H Hayakawa
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

3.  Comparison of the therapeutic effectiveness of aprindine, procainamide and quinidine in chronic ventricular dysrhythmias.

Authors:  J P Van Durme; M G Bogaert; M T Rosseel
Journal:  Br J Clin Pharmacol       Date:  1974-12       Impact factor: 4.335

4.  The metabolism of aprindine in relation to the sparteine/debrisoquine polymorphism.

Authors:  T Ebner; M Eichelbaum
Journal:  Br J Clin Pharmacol       Date:  1993-04       Impact factor: 4.335
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.